Bill A Pietra

Bill A Pietra, M.D.

Clinical Professor

Department: MD-COGNITAL HRT CTR EXCELLENCE
Business Phone: (352) 273-7770
Business Email: b.pietra@ufl.edu

About Bill A Pietra

Hi my name is Biagio Pietra but my patients call me Dr. Pietra or Dr. Bill. I am board-certified in general pediatrics and pediatric cardiology. I lead the pediatric cardiology program here at UF Health. I attended the University of Florida where I received my bachelor’s and post-baccalaureate degrees. I received my medical degree from the University of South Florida College of Medicine in Tampa, Florida. I completed my pediatric internship, pediatric residency and his pediatric cardiology fellowship at the Children’s Hospital Medical Center in Cincinnati.

I have spent most of my career as medical director for the pediatric cardiac transplant program and pediatric cardiac mechanical assist program at The Colorado Children’s Hospital, Aurora, where I also was an associate professor in the department of pediatrics, division of cardiology at the University of Colorado, Health Sciences.

I am honored to have received awards from the American Heart Association and National Institutes of Health-R01. I continue to review grants while serving on the National Institutes of Health-National Heart, Lung, and Blood Institute Study Sections.

I am also a fellow in the American Academy of Pediatrics and the American College of Cardiology and a member of the American Medical Association, the American Society of Transplantation and the International Society for Heart and Lung Transplantation. I also have served as a diplomat of the National Board of Medical Examiners.

Teaching Profile

Courses Taught
2018
MDC7400 Pediatric Clerkship

Board Certifications

  • Pediatric Cardiology
    American Board of Pediatrics
  • Pediatrics
    American Board of Pediatrics

Clinical Profile

Specialties
  • Pediatrics
Subspecialties
  • Congenital Heart Surgery
  • Pediatric Cardiology

Publications

Academic Articles
2018
Heart Transplantation for Adult Congenital Heart Disease: Overview and Special Considerations
Cardiovascular Innovations and Applications. 3(1):73-84 [DOI] 10.15212/CVIA.2017.0043.
2015
Cardiac Allograft Tolerance Induction Via Anti-Lfa-1 Monotherapy Is Dependent On An Indirect Cd8 T-Cell
Journal of Heart and Lung Transplantation. 34(4, S):S51-S52
2015
Single Drug Immunosuppression for Infant Heart Transplant Recipients
Journal of Heart and Lung Transplantation. 34(4, S):S322-S323
2010
First pediatric transatlantic air ambulance transportation on a Berlin Heart EXCOR left ventricular assist device as a bridge to transplantation.
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 11(2):e24-5 [DOI] 10.1097/PCC.0b013e3181bc5974. [PMID] 20216173.
2009
Outcome of extracorporeal membrane oxygenation for early primary graft failure after pediatric heart transplantation.
Journal of the American College of Cardiology. 54(8):730-7 [DOI] 10.1016/j.jacc.2009.04.062. [PMID] 19679252.
2005
Altered ventricular mechanics in cardiac allografts: a tissue Doppler study in 30 children without prior rejection events.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 24(11):1804-13 [PMID] 16297786.

Grants

Apr 2023 ACTIVE
CTOA
Role: Principal Investigator
Funding: UNIV OF FLORIDA
Jul 2021 – Jul 2024
Integrating Multi-parametric Echocardiography with Computer Assisted Analyses in Detection for Early Allograft Rejection in Pediatric Heart Transplant Recipients: A Pilot Prospective Multicenter Trial (ECHO-EZ)
Role: Principal Investigator
Funding: CLEVELAND CLINIC FOU via ENDURING HEARTS
Sep 2019 – May 2021
Integrating Multi-parametric Echocardiography with Computer Assisted Analyses in Detection for Early Allograft Rejection in Pediatric Heart Transplant Recipients: A Pilot prospective Multicenter Trial.
Role: Principal Investigator
Funding: ENDURING HEARTS
Sep 2017 – Sep 2023
Phase III Multi-center Open Label Randomized Clinical Trial Comparing Everolimus and Low Dose Tacrolimus to Tacrolimus to Tacrolimus and Mycophenolate Mofetil at 6 Months Post Heart Transplant to Prevent Long-Term Complications after Pediatric Heart Trans
Role: Principal Investigator
Funding: CHILDRENS HOSPITAL CORPORATION via US ARMY MED RES ACQUISITION
Jun 2016 – Aug 2023
A Prospective, Open-Label, Active-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of Age after the Fontan Procedure
Role: Principal Investigator
Funding: JANSSEN RESEARCH AND DEVELOPMENT

Contact Details

Phones:
Business:
(352) 273-7770
Emails:
Business:
b.pietra@ufl.edu
Addresses:
Business Mailing:
PO Box 100297
GAINESVILLE FL 32610
Business Street:
1600 SW ARCHER RD
GAINESVILLE FL 32610